These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17977482)

  • 1. Barriers to the initiation of, and persistence with, insulin therapy.
    Oliveria SA; Menditto LA; Ulcickas Yood M; Koo YH; Wells KE; McCarthy BD
    Curr Med Res Opin; 2007 Dec; 23(12):3105-12. PubMed ID: 17977482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
    Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
    Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation of Basal Insulin Analog Treatment for Type 2 Diabetes and Reasons Behind Patients' Treatment Persistence Behavior: Real-World Data from Germany.
    Moennig E; Perez-Nieves M; Hadjiyianni I; Cao D; Ivanova J; Klask R
    Exp Clin Endocrinol Diabetes; 2018 May; 126(5):287-297. PubMed ID: 28895642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan.
    Hadjiyianni I; Desai U; Suzuki S; Ivanova JI; Cao D; Kirson NY; Chida D; Enloe C; Birnbaum HG; Perez-Nieves M
    Diabetes Ther; 2017 Feb; 8(1):149-166. PubMed ID: 27913984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
    Mattoo V; Eckland D; Widel M; Duran S; Fajardo C; Strand J; Knight D; Grossman L; Oakley D; Tan M;
    Clin Ther; 2005 May; 27(5):554-67. PubMed ID: 15978304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].
    Schiel R; Müller UA; Stein G
    Med Klin (Munich); 2005 Aug; 100(8):453-61. PubMed ID: 16096726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes.
    Spain CV; Wright JJ; Hahn RM; Wivel A; Martin AA
    Clin Ther; 2016 Jul; 38(7):1653-1664.e1. PubMed ID: 27364806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of insulin initiation regimens in patients with type 2 diabetes mellitus: a large national medical records review study comparing a basal insulin analogue to premixed insulin.
    Sun P; Wang R; Jacober S
    Curr Med Res Opin; 2007 Dec; 23(12):3017-23. PubMed ID: 17961295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus.
    Rochester CD; Leon N; Dombrowski R; Haines ST
    Am J Health Syst Pharm; 2010 Jan; 67(1):42-8. PubMed ID: 20044368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for and time to discontinuation of rimonabant therapy: a modified prescription-event monitoring study.
    Willemen MJ; Mantel-Teeuwisse AK; Buggy Y; Layton D; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2012 Dec; 35(12):1147-58. PubMed ID: 23061737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.
    Borah BJ; Darkow T; Bouchard J; Aagren M; Forma F; Alemayehu B
    Clin Ther; 2009 Mar; 31(3):623-31. PubMed ID: 19393853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey.
    Perez-Nieves M; Ivanova JI; Hadjiyianni I; Zhao C; Cao D; Schmerold L; Kalirai S; King S; DeLozier AM; Birnbaum HG; Peyrot M
    Curr Med Res Opin; 2017 Oct; 33(10):1833-1842. PubMed ID: 28604111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil.
    Eliaschewitz FG; de Paula MA; Pedrosa HC; Pires AC; Salles JEN; Tambascia MA; A Turatti LA
    Diabetes Metab Syndr; 2018; 12(1):39-44. PubMed ID: 28864058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors related to adherence to statin therapy.
    McGinnis B; Olson KL; Magid D; Bayliss E; Korner EJ; Brand DW; Steiner JF
    Ann Pharmacother; 2007 Nov; 41(11):1805-11. PubMed ID: 17925498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming psychological barriers to insulin use in type 2 diabetes.
    Brunton SA; Davis SN; Renda SM
    Clin Cornerstone; 2006; 8 Suppl 2():S19-26. PubMed ID: 16939874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.